Eizen Joshua M - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 4, 2025, Eizen Joshua M's relationship to AN2 Therapeutics, Inc. (ANTX) is Officer (See Remarks), and currently has 177,353 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ANTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Eizen Joshua M - Insider Non-Derivative Transactions of ANTX Common Stock

Eizen Joshua M - Insider Non-Derivative Transactions at ANTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 5, 2025	Sell -- (Common Stock)	2819	1.14	177353
Feb 27, 2025	Acquisition -- (Common Stock)	58500	0	175172
Jan 4, 2025	Sell -- (Common Stock)	9663	1.34	116672
Nov 5, 2024	Acquisition -- (Common Stock)	31500	0	126335
Jul 11, 2024	Acquisition -- (Common Stock)	60000	0	94833
Mar 16, 2024	Acquisition -- (Common Stock)	30000	0	32447